Immunovant, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 101K | 105K | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | -101K | -105K | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 142.3M | 98.9M | 114.2M | 101.2M | 93.7M | 94.5M | 97.3M | 75.5M |
| Operating Expenses | 159.6M | 114.4M | 131.8M | 127.2M | 113.8M | 114.3M | 115.7M | 94.3M |
| Operating Income | -159.6M | -114.4M | -131.8M | -127.2M | -113.8M | -114.3M | -115.7M | -94.3M |
| Other Income / Gains | 8.9M | 5.3M | 5.9M | 7.5M | 8.0M | 3.3M | 6.7M | 7.2M |
| Net Income | -147.9M | -110.6M | -126.5M | -120.6M | -106.4M | -111.1M | -109.1M | -87.2M |
| EPS (Diluted) | -0.73 | -0.61 | -0.73 | -0.71 | -0.64 | -0.76 | -0.74 | -0.60 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 17.3M | 15.4M | 17.5M | 26.0M | 20.2M | 19.8M | 18.5M | 18.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 17.3M | 15.4M | 17.5M | 26.0M | 20.2M | 19.8M | 18.5M | 18.8M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 159.6M | 114.4M | 131.8M | 127.2M | 113.8M | 114.3M | 115.7M | 94.3M |
| Interest Income | 8.1M | 5.3M | 5.6M | 6.3M | 6.9M | 4.6M | 6.1M | 7.2M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 96K | 101K | 105K | 107K | 109K | 99K | 89K | 80K |
| Ebitda | -159.5M | -109.0M | -131.7M | -127.1M | -113.7M | -114.2M | -115.7M | -94.2M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -150.7M | -109.1M | -125.9M | -119.7M | -105.9M | -111.0M | -109.0M | -87.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | -2.8M | 1.6M | 594K | 913K | 583K | 152K | 78K | 77K |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.73 | -0.61 | -0.73 | -0.71 | -0.64 | -0.76 | -0.74 | -0.60 |
| Weighted Average Shs Out | 203.7M | 181.5M | 173.6M | 170.9M | 151.6M | 146.9M | 146.5M | 146.1M |
| Weighted Average Shs Out Dil | 203.7M | 181.5M | 173.6M | 170.9M | 151.6M | 146.9M | 146.5M | 146.1M |